DBV:EPA
DBV Technologies SA
1,59 €
arrow_upward
+1,66%(+0,026) 1D
19 հոկ, 17:35:06 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DBV...
Open
1,58 €
High
1,61 €
Low
1,53 €
Mkt. cap
473,43 մլն
Avg. vol.
1,11 մլն
Volume
1,17 մլն
52-wk high
4,50 €
52-wk low
1,53 €
EPS
-0,64 €
Shares outstanding
314,39 մլն
No. of employees
170
Open
1,58 €
High
1,61 €
Low
1,53 €
Mkt. cap
473,43 մլն
Avg. vol.
1,11 մլն
Volume
1,17 մլն
52-wk high
4,50 €
52-wk low
1,53 €
EPS
-0,64 €
Shares outstanding
314,39 մլն
No. of employees
170
News stories
From web sources and news partners
Simply Wall Street
·
6 րոպե առաջ
Inter & Co (NasdaqGS:INTR) Joins S&P Global BMI, Is It Still 21% Below Fair Value?
Trefis
·
29 րոպե առաջ
Market Movers | Winners: IRON, NAUT, ANNX | Losers: HPP, ALM, GEMI
Profile
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration. Wikipedia
About DBV Technologies SA